ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,947Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 2399

$2.81M Total Retail Price of All Prescriptions

Rank: 3 out of 2399

346 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Pennsylvania
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 346 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%. This is far more than peers.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

78 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
ATORVASTATIN CALCIUM 1,341 1,232 162 1 7
MONTELUKAST SODIUM 897 737 117 2 56
AMLODIPINE BESYLATE 896 816 118 3 4
CLOPIDOGREL 829 797 93 4 14
LEVOCETIRIZINE DIHYDROCHLORIDE 762 662 126 10 5 165
ADVAIR DISKUS 632 542 81 6 37
CRESTOR 602 532 85 7 31
CELEBREX 546 490 72 8 72
NEXIUM 486 437 67 9 35
METOPROLOL SUCCINATE 480 453 54 10 12
EVISTA 475 378 60 11 142
PROAIR HFA 472 384 83 12 70
PATADAY 471 424 82 13 320
PRAVASTATIN SODIUM 464 399 63 14 18
DEXILANT 440 411 61 15 178
EXFORGE 416 411* 48 16 190
METFORMIN HCL 392 355 53 17 9
LIDODERM 382 377* 53 18 139
PANTOPRAZOLE SODIUM 371 327 56 19 20
DIOVAN 356 333 45 20 30
PIOGLITAZONE HCL 318 313* 40 R 21 102
ZETIA 312 279 41 22 54
OMEPRAZOLE 312 261 47 22 5
AMMONIUM LACTATE 309 275 86 24 217
ATELVIA 299 294* 45 25 228
GLIMEPIRIDE 296 282 37 26 43
IBANDRONATE SODIUM 295 276 37 27 205
BISOPROLOL-HYDROCHLOROTHIAZIDE 251 210 29 28 159
PATANOL 249 233 38 29 323
LOVAZA 243 243 29 30 113
NASONEX 240 181 50 31 213
BYSTOLIC 232 227* 37 32 124
JANUMET 228 223* 31 33 191
JANUVIA 228 228 25 33 48
RANITIDINE HCL 217 161 29 35 45
FLUTICASONE PROPIONATE 215 175 43 36 42
TAMSULOSIN HCL 214 192 25 37 27
LOSARTAN POTASSIUM 207 179 36 38 16
NAMENDA 206 206 23 39 33
FAMOTIDINE* 206 190 38 39 60
AVODART 202 197* 21 41 170
MELOXICAM 201 158 33 42 68
SYMBICORT 200 146 29 43 163
FENOFIBRATE* 184 138 21 44 78
INDAPAMIDE 172 156 31 45 186
SPIRIVA 170 170 19 46 49
LEVOTHYROXINE SODIUM 168 155 22 47 2
FENOFIBRATE* 167 142 21 48 78
DONEPEZIL HCL 159 159 14 49 26
LOPERAMIDE 154 140 92 50 230
AZITHROMYCIN 152 130 111 51 47
GABAPENTIN 147 135 19 52 17
TRILIPIX 146 141* 24 53 305
MIRTAZAPINE 145 145 21 54 41
ALENDRONATE SODIUM 138 133* 26 55 34
TRAMADOL HCL 134 129* 40 56 25
ALLOPURINOL 131 119 22 57 32
DILTIAZEM 24HR CD 126 121* 17 58 99
TRIAMCINOLONE ACETONIDE 126 121* 43 58 128
VENTOLIN HFA 123 102 37 60 101
ACETAMINOPHEN-CODEINE 121 109 78 S3 61 130
VESICARE 120 115* 21 62 111
FUROSEMIDE 119 106 19 63 6
SPIRONOLACTONE 117 112* 17 64 71
COREG CR 116 101 17 65 317
POLYETHYLENE GLYCOL 3350 113 108* 23 66 64
WELCHOL 111 106* 17 67 201
ESCITALOPRAM OXALATE 108 77 16 68 39
ROPINIROLE HCL 106 101* 16 69 120
CALCIUM ACETATE 104 99* 16 70 238
BENICAR 103 103 12 71 97
MUPIROCIN* 100 83 50 72 252
COLCRYS 100 100 19 72 160
ACTONEL 98 93* 13 74 249
VOLTAREN 95 83 14 75 138
ATENOLOL 94 94 12 76 13
CLOBETASOL PROPIONATE 91 86* 34 77 232
ISOSORBIDE MONONITRATE ER 88 <11 <11 78 36
RAMIPRIL 85 80* 11 79 95
GLIPIZIDE ER 85 <11 <11 79 123
AZOR 85 85 12 79 275
METOPROLOL TARTRATE 84 79* 12 82 8
TRADJENTA 83 78* 13 83 206
FENOFIBRIC ACID 81 76* 25 84 500
CARVEDILOL 81 76* 12 84 28
PROCTOZONE-HC 77 55 20 86 210
CYMBALTA 77 64 14 86 63
SIMVASTATIN 75 57 16 88 1
ONGLYZA 75 75 11 88 271
CHLORHEXIDINE GLUCONATE 74 58 17 90 203
RAPAFLO 73 73 11 91 371
CIPROFLOXACIN HCL 72 67* 59 92 80
PROLIA 71 66* 46 93 506
EXELON 70 <11 <11 94 132
VIREAD 70 <11 <11 94 396
VIMOVO 69 <11 <11 96 509
HYDROCODONE-ACETAMINOPHEN 66 66 12 S3 97 15
NAPROXEN 63 47 20 98 109
PIOGLITAZONE-METFORMIN 63 <11 <11 R 98 368
VALSARTAN-HYDROCHLOROTHIAZIDE 62 <11 <11 100 66
NATEGLINIDE 60 <11 <11 101 272
AGGRENOX 59 <11 <11 102 166
LEVEMIR 58 <11 <11 103 195
HYDROCORTISONE VALERATE 58 53* 27 103 378
ULORIC 57 <11 <11 105 301
MECLIZINE HCL 56 51* 35 106 104
POTASSIUM CHLORIDE 55 50* 11 107 21
AMLODIPINE BESYLATE-BENAZEPRIL 54 <11 <11 108 69
BARACLUDE 54 <11 <11 108 553
COMBIVENT RESPIMAT 53 53 12 110 283
TEKTURNA HCT 53 <11 <11 110 557
WARFARIN SODIUM 52 <11 <11 112 10
ALFUZOSIN HCL 51 <11 <11 113 485
ZOLPIDEM TARTRATE 50 37 20 114 29
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.